Anticorps Polyclonaux Purifiés par Affinité à l’Antigène

Anti-Human GRO-γ (CXCL3)

0 ReviewsSubmit a Review

Product Details

Catalogue Number: 500-P105

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits pre-immunized with highly pure recombinant Human GRO-γ. Anti-Human GRO-γ specific antibody was purified by affinity chromatography employing immobilized Human GRO-γ matrix.

Immunogen: E.coli derived Recombinant Human GRO-γ (CXCL3) (PeproTech catalog# 300-40)

Sandwich ELISA: To detect Human GRO-γ by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Human GRO-γ (500-P105Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human GRO-γ.

Anti-Human GRO-γ (CXCL3) Sandwich ELISA

Western Blot: To detect Human GRO-γ by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 µg/ml. When used in conjunction with compatible secondary reagents, the detection limit for recombinant Human GRO-γ is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

Anti-Human GRO-γ (CXCL3) Western Blot Reduced Anti-Human GRO-γ (CXCL3) Western Blot Unreduced


Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information.

Country Of Origin: USA

Not for human use.

Research Interest


First Author
Mestas, J
The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma.
Journal of immunology (Baltimore, Md. : 1950); 175(8) pg5351-7
PubMed Id
First Author
Almeida, C R
NAP-2 Secreted by Human NK Cells Can Stimulate Mesenchymal Stem/Stromal Cell Recruitment.
Stem Cell Reports; 6(4) pg466-473
PubMed Id
First Author
White, E S
Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research; 9(2) pg853-60
PubMed Id